Eodyne
Provides the rehabilitation gaming system, a science-based treatment for effective recovery after brain damage.
- B2B
- B2C
- manufacturing
- commission
- health
- medical devices
- health platform
- artificial intelligence
- hardware
- big data
- deep tech
- virtual reality
- dt and ls
- horizon europe
- spinout
- core ai
- ai applications
- immersive technologies
- eit ecosystem
- neurology
- digital care
- eit health
- direct-to-consumer
- rehabilitation
- physician support tools
- hospital
- recovery
- patient engagement
- european health catapult (eit health)
- investor network (eit health)
- treatment assistance
- bridgehead europe (eit health)
- investor network 2018 (eit health)
- european health catapult 2016 (eit health)
- bridgehead europe 2018 (eit health)
- start-up-driven projects 2020 (eit health)
- start-up-driven projects (eit health)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
N/A | Support Program | ||
| Total Funding | 000k | ||
| EUR | 2022 | 2023 |
|---|---|---|
| Revenues | 0000 | 0000 |
| % growth | - | (4 %) |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| % profit margin | (37 %) | 30 % |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
Eodyne Systems, established in 2014, operates from Barcelona, Spain, as a spin-off from the Synthetic, Perceptive, Emotive and Cognitive Systems (SPECS) research group at Universitat Pompeu Fabra. The company was founded by Professor Dr. Paul F.M.J. Verschure, a neuroengineering professor who has dedicated nearly 30 years to developing a unified theory of the mind and brain. His academic journey through psychology, neuroscience, and AI across Europe and the US led to the creation of the core technology that underpins Eodyne. Carmen Buisan, a senior project manager at SPECS, is also a partner in the venture.
The firm is focused on the HealthTech sector, specifically developing and commercializing science-based neurorehabilitation technologies. Eodyne's primary clients are hospitals and rehabilitation centers, providing them with tools for treating patients who have suffered brain damage, particularly from stroke. The business model involves the sale and subscription of its main product, which aims to provide cost-effective solutions that reduce healthcare costs by enabling remote treatment, monitoring, and diagnostics. The company has received grant funding from investors including the European Union.
Eodyne's flagship product is the Rehabilitation Gaming System (RGS), an ICT and virtual reality-based platform designed to facilitate motor and cognitive recovery. RGS employs gamified scenarios that use computer vision to track a patient's movements and map them onto a virtual environment in real-time. A key feature is its adaptive algorithm, which personalizes the training intensity to match the patient's performance, maintaining an optimal level of challenge to enhance engagement and motivation. The system is designed for use throughout all phases of recovery, from in-hospital care to at-home therapy, ensuring continuity. Clinical studies have demonstrated that combining RGS with standard therapy can accelerate functional recovery by 20% over three months and that the improvements are maintained long-term. The platform is a CE-marked Class 1 Medical Device and is FDA listed.
Keywords: neurorehabilitation, virtual reality, stroke recovery, HealthTech, medical device, gamification, telerehabilitation, brain-computer interface, cognitive therapy, digital health